MERIT MEDICAL SYSTEMS INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.5B | $1.4B | $1.3B | $1.2B | $1.1B |
| Cost of revenue | $777.6M | $713.2M | $673.5M | $631.9M | $589.4M |
| Gross profit | $738.3M | $643.3M | $583.9M | $519.1M | $485.3M |
| Selling, general & administrative | $455.2M | $399.7M | $373.7M | $342.5M | $335.7M |
| Research and development | $97.4M | $87.5M | $82.7M | $75.5M | $71.2M |
| Operating expenses | $553.5M | $487.6M | $459.9M | $431.5M | $424.4M |
| Operating income | $184.7M | $155.7M | $123.9M | $87.6M | $60.9M |
| Interest expense | $26.5M | $31.2M | $15.5M | $6.3M | $5.3M |
| Pretax income | $170.9M | $150.0M | $112.1M | $82.6M | $53.9M |
| Income tax expense | $42.4M | $29.6M | $17.7M | $8.1M | $5.5M |
| Net income | $128.5M | $120.4M | $94.4M | $74.5M | $48.5M |
| Balance Sheet | |||||
| Cash and equivalents | $446.4M | $376.7M | $587.0M | $58.4M | $67.8M |
| Current assets | $1.0B | $923.8M | $1.1B | $529.1M | $482.2M |
| Total assets | $2.7B | $2.4B | $2.3B | $1.7B | $1.6B |
| Current liabilities | $239.8M | $216.4M | $203.6M | $220.6M | $236.3M |
| Total liabilities | $1.1B | $1.0B | $1.1B | $519.6M | $608.5M |
| Total debt | $747.5M | $747.5M | $846.6M | $198.2M | $243.1M |
| Stockholders' equity | $1.6B | $1.4B | $1.2B | $1.1B | $1.0B |
| Cash Flow Statement | |||||
| Cash from operations | $297.4M | $220.8M | $145.2M | $114.3M | $147.2M |
| Depreciation and amortization | $123.2M | $102.7M | $90.0M | $81.8M | $84.1M |
| Stock-based compensation | $43.5M | $28.5M | $21.3M | $18.0M | $16.1M |
| Capital expenditure | $81.7M | $35.1M | $34.3M | $45.0M | $27.9M |
| Free cash flow | $215.7M | $185.7M | $110.9M | $69.3M | $119.3M |
| Impairments | $0 | $0 | $270,000 | $2.2M | $4.3M |
Shares outstanding 59.7M · Free float 94.8%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.